<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04674761</url>
  </required_header>
  <id_info>
    <org_study_id>A4250-012</org_study_id>
    <nct_id>NCT04674761</nct_id>
  </id_info>
  <brief_title>Efficacy and Safety of Odevixibat in Patients With Alagille Syndrome</brief_title>
  <acronym>ASSERT</acronym>
  <official_title>A Phase 3 Double-blind, Randomized, Placebo-controlled Study of the Safety and Efficacy of Odevixibat (A4250) in Patients With Alagille Syndrome (ASSERT)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Albireo</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Albireo</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Double-blind, randomized, placebo-controlled, Phase 3 study to investigate the efficacy and&#xD;
      safety of odevixibat compared to placebo in Patients with Alagille Syndrome.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Approximately 35 sites will be initiated for this study in North America, Europe, Middle&#xD;
      East, and Asia Pacific.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 19, 2021</start_date>
  <completion_date type="Anticipated">July 2022</completion_date>
  <primary_completion_date type="Anticipated">June 2022</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change from Baseline in Scratching Score</measure>
    <time_frame>From baseline to Week 24</time_frame>
    <description>Change from baseline in scratching score to Month 6 as measured by the Albireo Observer-Reported Outcome scratching score</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Serum Bile Acid Levels</measure>
    <time_frame>From baseline to Week 24</time_frame>
    <description>Change in serum bile acid levels from baseline to Week 24</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Safety and Tolerability</measure>
    <time_frame>From first dose of study drug up to 28 days after last dose of study drug or to the completion of study participation date, whichever occurs first</time_frame>
    <description>Safety and Tolerability as Assessed by Number of Participants With Treatment-Emergent Adverse Events (AEs) and Serious Adverse Events (SAEs)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">63</enrollment>
  <condition>Alagille Syndrome</condition>
  <arm_group>
    <arm_group_label>Odevixibat (A4250)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Capsules for oral administration once daily for 24 weeks.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Capsules for oral administration (to match active) once daily for 24 weeks.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Odevixibat</intervention_name>
    <description>Odevixibat is a small molecule and selective inhibitor of IBAT.</description>
    <arm_group_label>Odevixibat (A4250)</arm_group_label>
    <other_name>A4250</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Placebo identical in appearance to experimental drug (odevixibat).</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Key Inclusion Criteria:&#xD;
&#xD;
          -  Genetically confirmed diagnosis of Alagille syndrome&#xD;
&#xD;
          -  History of significant pruritus as measured by the Albireo Observer or Patient&#xD;
             Reported Outcome instrument&#xD;
&#xD;
          -  Elevated serum bile acid level&#xD;
&#xD;
        Key Exclusion Criteria:&#xD;
&#xD;
          -  History or ongoing presence of other types of liver disease (eg. biliary atresia,&#xD;
             progressive familial intrahepatic cholestasis, hepatocellular carcinoma)&#xD;
&#xD;
          -  History of liver transplant, or a liver transplant is planned within 6 months of&#xD;
             randomization&#xD;
&#xD;
          -  ALT &gt;10× upper limit of normal (ULN) at screening&#xD;
&#xD;
          -  Total bilirubin &gt;15 × ULN at screening&#xD;
&#xD;
          -  Patient suffers from uncontrolled, recalcitrant pruritic condition other than Alagille&#xD;
             syndrome&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Albireo</last_name>
    <phone>+1 (857) 378-2035</phone>
    <email>medinfo@albireopharma.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>University of California - San Francisco</name>
      <address>
        <city>San Francisco</city>
        <state>California</state>
        <zip>94158</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Joanna Curry</last_name>
      <email>joanna.curry@ucsf.edu</email>
    </contact>
    <investigator>
      <last_name>Philip Rosenthal, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Johns Hopkins Hospital</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21287</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Naureen Islam</last_name>
      <phone>410-614-8583</phone>
      <email>nislam5@jhmi.edu</email>
    </contact>
    <contact_backup>
      <last_name>Ashley Thomas</last_name>
      <phone>410-955-9161</phone>
      <email>ashley_thomas@jhmi.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Wikrom Karnsakul, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ann Scheimann, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Boston Children's Hospital</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02115</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Shavonne Osiakwan</last_name>
      <phone>617-355-0530</phone>
      <email>shavonne.osiakwan@childrens.harvard.edu</email>
    </contact>
    <investigator>
      <last_name>Andrew Wehrman</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Children's Mercy Hospital and Clinics</name>
      <address>
        <city>Kansas City</city>
        <state>Missouri</state>
        <zip>64108</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Heather Wasserkrug</last_name>
      <phone>816-302-3043</phone>
      <email>hwasserkrug@cmh.edu</email>
    </contact>
    <contact_backup>
      <last_name>Lisa Harvey</last_name>
      <phone>816-302-3044</phone>
      <email>lkharvey@cmh.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Ryan Fisher, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Childrens Hospital at Montefiore Albert Einstein School of Medicine</name>
      <address>
        <city>Bronx</city>
        <state>New York</state>
        <zip>10467</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Megan Leary</last_name>
      <email>mleary@montefiore.org</email>
    </contact>
    <contact_backup>
      <last_name>Trang Nguyen, NP</last_name>
      <phone>7187412332</phone>
      <email>trannguy@montefiore.org</email>
    </contact_backup>
    <investigator>
      <last_name>Nadia Ovchinsky, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Icahn School of Medicine at Mount Sinai</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10029</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marjorie Nisenholtz</last_name>
      <phone>212-659-8049</phone>
      <email>marjorie.nisenholtz@mountsinai.org</email>
    </contact>
    <contact_backup>
      <last_name>Brandy Haydel</last_name>
      <phone>212-241-0255</phone>
      <email>brandy.haydel@mountsinai.org</email>
    </contact_backup>
    <investigator>
      <last_name>Jaime Chu, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Columbia University Medical Center</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10032</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Isaac Effiong</last_name>
      <phone>212-305-3839</phone>
      <email>ie2222@cumc.columbia.edu</email>
    </contact>
    <investigator>
      <last_name>Jennifer Vittorio, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Oregon Health Science University School of Medicine</name>
      <address>
        <city>Portland</city>
        <state>Oregon</state>
        <zip>97239</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Cristina Martinez-Singh</last_name>
      <phone>503-418-8108</phone>
      <email>martincr@ohsu.edu</email>
    </contact>
    <investigator>
      <last_name>Henry Lin, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>UPMC Children's Hospital of Pittsburgh</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15224</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Amy Bookser</last_name>
      <phone>412-692-8453</phone>
      <email>amy.bookser@chp.edu</email>
    </contact>
    <investigator>
      <last_name>James Squires, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Cliniques Universitaires Saint-Luc Bruxelles</name>
      <address>
        <city>Brussels</city>
        <zip>1200</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sandrine Lambert</last_name>
      <phone>+32 2 764 13 36</phone>
      <email>sandrine.lambert@uclouvain.be</email>
    </contact>
    <investigator>
      <last_name>Etienne Sokal, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU Sainte-Justine</name>
      <address>
        <city>Montréal</city>
        <state>Quebec</state>
        <zip>H3T 1C5</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sylvannie Tchouda</last_name>
      <phone>514-345-4931</phone>
      <phone_ext>7729</phone_ext>
      <email>sylvannie.tchouda.hsj@ssss.gouv.qc.ca</email>
    </contact>
    <investigator>
      <last_name>Marie-Eve Chartier, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpital Femme Mère Enfant de Lyon</name>
      <address>
        <city>Bron</city>
        <zip>69677</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Audrey Trouillot</last_name>
      <phone>33,472,681,343</phone>
      <email>audrey.trouillot@chu-lyon.fr</email>
    </contact>
    <contact_backup>
      <last_name>Lioara Restier</last_name>
      <phone>33,427,856,020</phone>
      <email>lioara.restier@chu-lyon.fr</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Antenne pédiatrique du CIC - Hopital Jeanne De Flandre</name>
      <address>
        <city>Lille</city>
        <zip>59037</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alban Vandamme</last_name>
      <phone>03 20 44 60 58</phone>
      <email>alban.vandamme@chru-lille.fr</email>
    </contact>
    <contact_backup>
      <last_name>Amina Ziouche</last_name>
      <phone>03 20 44 60 58</phone>
      <email>amina.ziouche@chru-lille.fr</email>
    </contact_backup>
    <investigator>
      <last_name>Madeleine Aumar, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>APHM</name>
      <address>
        <city>Marseille</city>
        <zip>13385</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Aurelie Larosa</last_name>
      <phone>04 91 43 52 60</phone>
      <email>aurelie.larosa@ap-hm.fr</email>
    </contact>
    <contact_backup>
      <last_name>Valentine Verdier</last_name>
      <phone>04 91 38 12 74</phone>
      <email>valentine.verdier@ap-hm.fr</email>
    </contact_backup>
    <investigator>
      <last_name>Bertrand Roquelaure, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hopital Necker Enfants Malades</name>
      <address>
        <city>Paris</city>
        <zip>75015</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nabila Aknouche</last_name>
      <phone>01 44 49 47 58</phone>
      <email>nabila.oussalem@aphp.fr</email>
    </contact>
    <contact_backup>
      <last_name>Déborah Rechard</last_name>
      <email>deborah.rechard@aphp.fr</email>
    </contact_backup>
    <investigator>
      <last_name>Florence Lacaille, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Medizinische Hochschule Hannover</name>
      <address>
        <city>Hannover</city>
        <zip>30625</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Katarina Migal</last_name>
      <phone>+49 511 532 9022</phone>
      <email>migal.katarina@mh-hannover.de</email>
    </contact>
    <investigator>
      <last_name>Ulrich Baumann, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Universitätsklinik für Kinder-und Jugendmedizin Tübingen</name>
      <address>
        <city>Tübingen</city>
        <zip>72076</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Susanne Schwartz</last_name>
      <phone>4970712981446</phone>
      <email>susanne.schwartz@med.uni-tuebingen.de</email>
    </contact>
    <contact_backup>
      <last_name>Hiltrud Mayer</last_name>
      <phone>4970712981399</phone>
      <email>Hiltrud.Mayer@med.uni-tuebingen.de</email>
    </contact_backup>
    <investigator>
      <last_name>Ekkehard Sturm, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>AOU Meyer</name>
      <address>
        <city>Firenze</city>
        <zip>50139</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Katia Tortora</last_name>
      <email>katia.tortora@meyer.it</email>
    </contact>
    <investigator>
      <last_name>Giuseppe Indolfi, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Mariangela Stinco, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Azienda Ospedale Università Padova</name>
      <address>
        <city>Padova</city>
        <zip>35128</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Francesca Venturini</last_name>
      <email>farmacia@aopd.veneto.it</email>
    </contact>
    <investigator>
      <last_name>Mara Cananzi</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Universitair Medisch Centrum Groningen (UMCG)</name>
      <address>
        <city>Groningen</city>
        <zip>9713 GZ</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rinske van der Heide</last_name>
      <phone>0031 6 26650786</phone>
      <email>r.t.van.der.heide@umcg.nl</email>
    </contact>
    <contact_backup>
      <last_name>Sandra Dijkstra</last_name>
      <phone>0031 6 25647353</phone>
      <email>bwok@umcg.nl</email>
    </contact_backup>
    <investigator>
      <last_name>H.J. Verkade, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Medical Centre Utrecht, WKZ</name>
      <address>
        <city>Utrecht</city>
        <zip>3584EA</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sabine Michel</last_name>
      <phone>06-11619164</phone>
      <email>s.michel-2@umcutrecht.nl</email>
    </contact>
    <contact_backup>
      <last_name>Stephan Jans</last_name>
      <phone>088-7575146</phone>
      <email>S.R.Jans-2@umcutrecht.nl</email>
    </contact_backup>
    <investigator>
      <last_name>W Van der Woerd</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Instytut Pomnik-Centrum Zdrowia Dziecka</name>
      <address>
        <city>Warszawa</city>
        <zip>04-730</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Małgorzata Pisera</last_name>
      <phone>790023526</phone>
      <email>mpisera@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Piotr Czubkowski, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>King's College Hospital</name>
      <address>
        <city>London</city>
        <zip>SE5 9RS</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Katie Tupper</last_name>
      <phone>7590074458</phone>
      <email>katietupper@nhs.net</email>
    </contact>
    <investigator>
      <last_name>Alastair Baker</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Belgium</country>
    <country>Canada</country>
    <country>France</country>
    <country>Germany</country>
    <country>Italy</country>
    <country>Netherlands</country>
    <country>Poland</country>
    <country>United Kingdom</country>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>December 10, 2020</study_first_submitted>
  <study_first_submitted_qc>December 17, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">December 19, 2020</study_first_posted>
  <last_update_submitted>November 15, 2021</last_update_submitted>
  <last_update_submitted_qc>November 15, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 16, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>ALGS</keyword>
  <keyword>Alagille syndrome</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Alagille Syndrome</mesh_term>
    <mesh_term>Syndrome</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

